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Diagnosis and control of 
polypharmacy in the elderly
Diagnóstico e controle da 
polifarmácia no idoso
ABSTRACT
The article had the purpose of commenting on studies on polypharmacy in the 
elderly, focusing on diagnosis and control. Polypharmacy is defi ned as the use 
of a number of medications at the same time and the use of additional drugs to 
correct drug adverse effects. The fact that the elderly take more medications for 
the treatment of several diseases makes them more susceptible to the occurrence 
of adverse reactions. Prophylactic actions such as balanced prescriptions are 
vital to reduce the incidence of these reactions and prevent longer hospital stay, 
increased costs and aggravation of the elderly health condition.
KEY WORDS: Health of the elderly. Drug therapy, combination. 
Prescriptions, drug. Drug interactions. Drugs of continuous use. 
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RESUMO
O artigo teve por objetivo comentar estudos sobre polifarmácia em idosos, 
particularmente em diagnose e controle. O conceito de polifarmácia considera 
o uso de diversos medicamentos ao mesmo tempo, além da utilização de 
um fármaco para corrigir o efeito adverso de outro. Por consumirem mais 
medicamentos para o tratamento de diversas doenças, os idosos são mais 
vulneráveis ao surgimento de reações adversas. Medidas profi láticas, como a 
prescrição balanceada, são de fundamental importância para diminuir essas 
reações, tendo em vista o aumento do tempo de internação, gasto e piora do 
quadro de saúde do idoso.
DESCRITORES: Saúde do idoso. Quimioterapia combinada. Prescrição 
de medicamentos. Interações de medicamentos. Medicamentos de uso 
contínuo. Comentário [Tipo de publicação].
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Signifi cant advancement on medical sciences towards 
greater life expectancy has been seen in recent years. 
This benefi t came with concurrent increasing costs 
for life quality promotion, including people’s access 
to medications. The growth of elderly population is 
signifi cant, and many people will need low or high-
complexity multiple drug therapy due to the existence 
of acute or chronic diseases.
Population studies in Brazil show that at least 85% of 
the elderly have at least one chronic disease and about 
10% of them have at least fi ve diseases.26
The use of multiple medications can potentially provide 
substantial benefi t in controlling many chronic diseases. 
But some polypharmacy therapies are inappropriate, 
leading to adverse drug reactions and interactions.
The objective of the present study was to comment on 
studies on polypharmacy in the elderly, particularly 
regarding its diagnosis and control.
DEFINITIONS OF POLYPHARMACY
The defi nition of polypharmacy is still controversial. 
However, it may be defi ned as the use of one medication 
to correct the adverse effect of another or the increase 
on the number of medications considering fi ve or more 
associations.1,6,12,28
Topical and herbal medications are generally excluded 
of this defi nition as they are often not included in the 
traditional methods of assessing prescription quality. 
Vitamins and minerals taken on as-needed basis are 
also generally excluded in these assessments because 
of the inconsistent inclusion of these medications in 
polypharmacy.
The duration of therapy has been another criterion des-
cribed to defi ne polypharmacy. Veehof et al29 defi ned 
a minimum period of 60 days. However, this criterion 
has not yet been validated.
The diagnostic of several concomitant conditions may 
lead to polypharmacy. Considering the large number of 
polypharmacy concepts, there is need of an agreement 
in relation to this defi nition to evaluate its frequency, 
control its occurrence and to identify the risk of adverse 
reactions associated with polypharmacy.
EPIDEMIOLOGY OF POLYPHARMACY AND 
CLINICAL OUTCOMES
Although scarce, some data show a growing elderly 
population in Brazil. In a study comparing the 1980 
and 2000 age group population pyramids, an increase 
was seen in the population older than 60 years, from 
6.1% to 8.6%.15
Due to an increased lifespan of the elderly both in deve-
loped and developing countries, identifying medication 
interactions aimed at preventing adverse drug reactions 
becomes paramount. Proportionally, the elderly use 
more drugs compared to other age groups. In Brazil, 
Passarelli et al23 reported an average between 9.9 and 
13.6 drugs in inpatients. The number of medications 
used in outpatient treatment was lower, ranging from 
1.3 to 2.3 drug/patient.8
A Brazilian study investigated 45 elderly and found 
that polypharmacy in 33.3%. Antihypertensive agents 
were the most commonly used drugs, accounting for 
53.3% of prescriptions.3
A 32% prevalence was found for cardiovascular 
medications in another prospective study involving 
hospitalized or bedridden elderly patients. It was also 
observed that of those who took drugs with tea (57%), 
12% did not believe tea could reduce the therapeutic 
effi ciency.10
Loyola et al17 showed an association between the 
number of medical consultations and use of prescribed 
medications. Self-medication rate was lower among 
those who attended periodical medical consultations 
and high self-medication rates may be associated to 
lack of medical care. In contrast to studies conducted 
in developed countries, lower use of prescribed medica-
tions among elderly patients with lower socioeconomic 
condition was seen.17
In one of the few prospective studies on polypharmacy, 
Veehof et al29 followed up 1,544 elders for three years, 
and identifi ed a 42% incidence rate of polypharmacy. 
The number of medications used in the long term at 
the beginning of the cohort was the best predictor of 
polypharmacy development. The incidence of arterial 
hypertension and atrial fi brillation was associated to 
signifi cant increase in polypharmacy (risk ratio of 37.3 
and 19.6, respectively).29
In addition, the elderly above 86 years of age had an 
increase in hospital admission at emergency department 
from 12% to 21%.1 In the same study, the number of 
elders admitted to hospitals in an urban area was three 
times higher than those in a rural area. Also, the number 
of elderly patients who attended emergency services 
decreased, suggesting changes in the behavior of elders 
who live in a rural area compared to those who live in 
an urban area, with no references on how the changes 
occurred.1
In regard to the incidence of polypharmacy in outpa-
tients, a study25 found fi ve chronic diseases on average 
per elderly, who took about 11 medications each. 
Also, it was found that 81% of them had prescriptions 
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considered as inadequate, had inadequate treatment 
adherence or used drugs with narrow safety margin, 
which could cause medication toxicity.25 In Brazil, me-
dication cost is directly proportional to the increase in 
the population age. The same can be found in developed 
countries, where the expenditure with medications for 
elderly patients proportionally increases as longevity 
increases, having a great impact on these countries’ 
economies.21
ECONOMIC IMPACT OF POLYPHARMACY
In England, there was a progressive increase in me-
dication consumption among the elderly for 20 years 
(1979–98). In the United States, the increase in me-
dication expenditure from 1991 to 2000 was around 
8.5%. Japan, on the other hand, had a disproportional 
growth with an estimated expenditure per elder in 1991 
of US$ 130 per capita.21
An increased consumption of herbal remedies in this 
age group was also seen as they are sold over the 
counter, thus facilitating access to these drugs without 
requiring medical prescription. Herbal remedies are part 
of the so-called complementary therapy.
Although these medications are not yet regulated, they 
account for US$ 13 billion in sales in the year of 2000 
in the United States. It was found that patients do not 
report to their physicians the use of these products, 
which can interact with other drugs and increase the 
risk of adverse reactions due to drug interactions as 
well as the costs to minimize these effects.7
Three factors have been indicated as key for increased 
costs with medications in the elderly: increased use of 
prescribed medications, increased costs of prescription 
drugs and the advent of new drugs. This increased ex-
penditure due to a greater number of prescribed drugs 
could be minimized by using less costly drugs.4
The association between urinary incontinence, delirium 
and polypharmacy is common in people older than 50 
years. Drugs used in the treatment of urinary incon-
tinence are usually adrenergic, sometimes inducing 
delirium as an adverse effect. As it requires a different 
drug to reduce this adverse effect, this combination 
characterizes polypharmacy. In turn, polypharmacy 
itself may cause several complications, among them 
urinary incontinence and delirium.13
Other factors associated to polypharmacy in the elderly 
include the number of serious diseases which require 
a higher number of medications for its treatment and 
incur in higher expenditure with physicians and phar-
macists as more providers will be involved.16
Admission rates may increase since increasing popu-
lation age is associated to higher risk of side effects in 
the elderly, a condition that can be aggravated by the 
use of polypharmacy.5
The most commonly complications associated to adver-
se drug reactions include gastrointestinal complications, 
accounting for 19%, and metabolic and hemorrhagic 
complications. The most commonly drugs involved in 
these events are diuretics, calcium blockers (9%), di-
goxin (8%), and nonsteroidal anti-infl ammatory agents 
(8%).22 Adverse drug effects produced an increased 
rate of hospital admission in elderly patients of around 
4% and 38 (4%) died due to adverse drug effects. For 
each drug used by the elder, there is a 65% increase 
in the likelihood of hospital admission due to adverse 
drug effects.22
POLYPHARMACY CONTROL MEASUREMENTS
Pharmaceutical care plays an important role in the 
reduction of polypharmacy in the elderly. Pharmacists 
evaluate aspects concerning the use of adequate medi-
cations; reduction of medication doses without affecting 
treatment effi ciency; adjustment of doses beyond the 
drug safety margin; and correct use of the medication 
by elderly patients.27
The role of a clinical pharmacist has been confi rmed as 
vital in the development of recommendations for both 
physicians and patients. A prospective study has shown 
a reduction of 24% in the use of inappropriate drugs 
as well as signifi cant reduction in adverse drug effects 
when compared to the control group.18
Treatment adherence of the elderly patient is another 
factor that impairs polypharmacy reduction. Medication 
adherence can be defi ned as consistency between me-
dical prescription and drugs consumed by the patient.20 
Compliance is lower among elders older than 85 years 
compared to those aged from 60 to 74 years. Another 
factor that contributes to the reduction of drug bioa-
vailability is the fact that older adults drink less water 
and tend to take their medication with food, and make 
use of drugs, such as tranquilizers and laxative agents, 
by themselves.19
Interviews with patients, counting of pills and even 
electronic methods of pill counting are some measure-
ments used to improve drug therapy adherence. These 
methods have both advantages and disadvantages. Pill 
counting provides an estimative of the number of pills 
consumed but does not take into consideration the time 
these pills are taken.14
The methods employed to control and reduce polyphar-
macy in the elderly are complex and pose a great chal-
lenge. Randomized clinical studies have shown that 
programmed interventions reduce polypharmacy for a 
short period only.24 It seems that the decision of using 
or not prescribed medications in most cases depends 
on the preference of physicians and patients.
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ced costs of drug treatment. Thus, the reduction of the 
number of drugs prescribed requires a multidisciplinary 
approach by health professionals, and the adaptation of 
the elder in the social and family environment is vital. 
All these factors allow the elderly to live a mentally and 
physically healthy and harmonic life, resulting in the 
reduction in medication use especially anti-depressive 
agents and sedatives.
Actions for rational drug use are countless and their 
main focus is polypharmacy control and medication 
cost reduction. Among the main measures, there is 
the so-called safe prescription, defi ned as the process 
that recommends an adequate medication for a given 
patient in ideal conditions, providing a balance between 
therapeutical activity and adverse effect. First of all, a 
prescription should be safe. In this context, the balanced 
prescription considers the physiological changes of the 
elderly and the adverse effects of the drugs aiming at 
an adequate dose which should be possible with the 
individualization of the therapy.2
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Another factor that could contribute to reduce polyphar-
macy complications is the reduction on confl icting 
information given by many different health profes-
sionals.9
The use of medications including beta-blocker drugs, 
sympathomimetic drugs, sedatives, hypnotic drugs, 
opiates, tricyclic antidepressive agents, antipsychotics 
and corticosteroids can produce signifi cant physiolo-
gical changes. The two drug classes most commonly 
associated to side effects include cardiovascular drugs 
(especially beta-blockers and diuretics) and those ac-
ting in the central nervous system (benzodiazepines). 
Moreover, there is a potential risk due to four factors 
including age, co-morbidities, number of drugs prescri-
bed and number of drugs discontinued during treatment. 
A reduction of 26% in medication consumption and 
rational use of medications in the elderly was found al-
though polypharmacy adverse effects were not reduced 
with a reduced number of medications.11
A number of methods have been proposed for polyphar-
macy reduction. Some authors point as vital for 
polypharmacy control the reduction of adverse effects 
since several drug interactions can be anticipated and 
prescriptions can be adjusted.5 This also leads to redu-
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